498 related articles for article (PubMed ID: 16202854)
1. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.
Dahlöf B; Degl' Innocenti A; Elmfeldt D; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Tanser P; Toutouzas P; Waeber B; Wiklund I
Am J Hypertens; 2005 Oct; 18(10):1313-9. PubMed ID: 16202854
[TBL] [Abstract][Full Text] [Related]
2. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
Frishman WH; Hainer JW; Sugg J;
Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
[TBL] [Abstract][Full Text] [Related]
3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
5. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
[TBL] [Abstract][Full Text] [Related]
6. Optimal felodipine dose when combined with metoprolol in arterial hypertension: a Swedish multicenter study within primary health care. Swedish General Practitioner Felodipine Study Group.
Brun J; Fröberg L; Kronmann P; Olsson LB; Skoog P; Tygesen G; Bengtsson C; Scherstén B; Tibblin G
J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S60-4. PubMed ID: 1693732
[TBL] [Abstract][Full Text] [Related]
7. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
8. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
Papademetriou V; Hainer JW; Sugg J; Munzer D;
Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
[TBL] [Abstract][Full Text] [Related]
9. Low dosages of felodipine ER once daily as monotherapy in elderly hypertensive patients: effect on ambulatory blood pressure and quality of life.
van Ree JW; van der Pol GA
J Hum Hypertens; 1996 Sep; 10(9):613-8. PubMed ID: 8953207
[TBL] [Abstract][Full Text] [Related]
10. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.
Hoffmann J
Blood Press Suppl; 1993; 1():30-6. PubMed ID: 8173688
[TBL] [Abstract][Full Text] [Related]
12. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
13. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS
J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
[TBL] [Abstract][Full Text] [Related]
14. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
15. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
[TBL] [Abstract][Full Text] [Related]
17. Improved efficacy with maintained tolerability in the treatment of primary hypertension. Comparison between the felodipine-metoprolol combination tablet and monotherapy with enalapril. Swedish Multicentre Group.
Andersson OK
J Hum Hypertens; 1999 Jan; 13(1):55-60. PubMed ID: 9928753
[TBL] [Abstract][Full Text] [Related]
18. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
[TBL] [Abstract][Full Text] [Related]
19. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
20. Felodipine-metoprolol combination tablet: a valuable option to initiate antihypertensive therapy?
Waeber B; Detry JM; Dahlöf B; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Safar M; Tanser P; Toutouzas P
Am J Hypertens; 1999 Sep; 12(9 Pt 1):915-20. PubMed ID: 10509550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]